Don't judge a book by its cover: The role of statins in liver cancer

N Piekuś-Słomka, LP Mocan, R Shkreli, C Grapă… - Cancers, 2023 - mdpi.com
Simple Summary Statins are a group of remedies developed to treat lipid disorders
associated with cardiovascular diseases. Thanks to their high efficiency, they are the primary …

Current status and perspectives in the surgical and oncological management of intrahepatic cholangiocarcinoma

A Dhote, S Tzedakis, OI Shapira, A Nassar… - Journal of Visceral …, 2023 - Elsevier
Intrahepatic cholangiocarcinoma (ICC) is the second most common primary liver tumor after
hepatocellular carcinoma (HCC). Management depends on their resectability at the time of …

Preparation and characterization of a magnetic microsphere synthesized from sucrose allyl ether for transcatheter arterial embolization

Y Lun, Y Zhou, Q Li, P Chen, Y Huang, G Ye - Materials Today Chemistry, 2022 - Elsevier
The polymerization of allyl monomers has been reported as notoriously difficult because of
degradative chain transfer induced by the allyl radical as a primary radical with resonance …

Sulfasalazine sensitizes polyhematoporphyrin-mediated photodynamic therapy in cholangiocarcinoma by targeting xCT

YW Zheng, XY Miao, L Xiong, B Chen… - Frontiers in …, 2021 - frontiersin.org
Cholangiocarcinoma (CCA), which is highly malignant, shows a relatively poor prognosis,
due to the insensitivity of the tumour to chemotherapy and radiotherapy. Photodynamic …

Clinical Effectiveness of Drug-Eluting Microsphere Transcatheter Arterial Chemoembolization Combined with First-Line Chemotherapy as the Initial Treatment for …

S Luo, Z Xiang, M Li, C Zhao, H Yan… - Journal of Vascular and …, 2024 - Elsevier
Purpose To evaluate the safety and effectiveness of the combination of drug-eluting
microsphere (DEM) transcatheter arterial chemoembolization (TACE) with those of …

Locoregional therapy combined with systemic therapy (LRT+ ST) for unresectable and metastatic intrahepatic cholangiocarcinoma: a systematic review and meta …

M Zhang, W Qi, X Qiu, C Yu, W Qiu, S Wang… - Radiology and …, 2023 - sciendo.com
Background. The outcome of systemic therapy (ST) for unresectable and metastatic
intrahepatic cholangiocarcinoma (iCCA) is poor. This study aims to further evaluate the …

[PDF][PDF] 胆管癌新辅助治疗研究进展

陈瑞秋, 张志磊, 彭利 - 肝胆胰外科杂志, 2023 - gdy.qk.wmu.edu.cn
胆管癌由于恶性程度较高, 仅约三分之一的患者初诊时具备手术切除指征.
新辅助治疗具有抗肿瘤活性作用, 可提高R0 切除率和改善远期预后, 使更多的胆管癌患者从中获 …

[HTML][HTML] 肝外胆管癌的介入治疗现状与展望

王宏博, 杨业发, 葛乃建 - 中国癌症杂志, 2022 - china-oncology.com
肝外胆管癌是指源于肝外胆管包括肝门区至胆总管下端胆管的恶性肿瘤. 在美国癌症联合会(
American Joint Committee on Cancer, AJCC) 第8 版指南中, 肝外胆管癌被分类分为肝门胆管 …

Actualités et perspectives dans la prise en charge chirurgicale et oncologique des cholangiocarcinomes intrahépatiques

A Dhote, S Tzedakis, OI Shapira, A Nassar… - Journal de Chirurgie …, 2023 - Elsevier
Résumé Le cholangiocarcinome intrahépatique (CCI) représente la deuxième tumeur
primitive du foie après le carcinome hépatocellulaire (CHC). La prise en charge de ces …

Progress in interventional therapy of extrahepatic cholangiocarcinoma

W Hongbo, Y Yefa, GE Naijian - China Oncology, 2022 - china-oncology.com
Extrahepatic cholangiocarcinoma refers to a malignant tumor originating from the
extrahepatic bile duct, including the bile duct from the hilar area to the lower end of the …